What is Stilnox (zolpidem), and what is it prescribed for?

In short

• Stilnox is zolpidem, a Z-drug, not a benzodiazepine. It binds a narrower part of the GABA-A receptor than diazepam or Urbanol do, though South African regulators still list it under the same Schedule 5 controls.
• The adult dose is 10 mg, and it is lower for women and older adults.SAHPRA’s approved package insert caps the adult dose at 10 mg, and a lower 5 mg dose is recommended for women.
• Treatment is meant to last days, not months. SAHPRA limits a course to a maximum of four weeks, tapering included, and stopping suddenly after that point can bring the original insomnia back, worse than before.

Worried that a short course of Stilnox has turned into something longer? Book a free, confidential call with our team. We reply the same day.

A doctor writes a script for Stilnox after a run of bad nights, and the patient walks out of the room still not quite sure what they have just been handed, only that they want to finally sleep through one. Some search the name before the box is even open.

Stilnox works, and that is exactly why it needs a closer look: what it actually is, how it is meant to be dosed, and where a short-term aid for bad nights can turn into a longer problem than the one it was meant to solve.

What is Stilnox, and what is it prescribed for?

Stilnox is the South African brand name for zolpidem, a short-term sleeping tablet registered under Schedule 5. SAHPRA’s approved package insert states that Stilnox is indicated for the short-term treatment of insomnia, and only when the disorder is severe, disabling or causing extreme distress, not for ordinary poor sleep.

Despite the label it is often given online, zolpidem is not a benzodiazepine. It is an imidazopyridine that binds with high affinity to GABA-A receptors containing the alpha1 subunit, according to a peer-reviewed study of how zolpidem acts on those receptors, a narrower target than benzodiazepines act on. The same paper also notes that zolpidem modulates tonic GABA currents differently from benzodiazepines, a separate pharmacological difference between the two drug classes. Pharmacologically, then, zolpidem and a benzodiazepine such as diazepam are not the same drug, even though South Africa lists both under Schedule 5 for the same practical reason: both need a doctor’s prescription and both carry a real risk of misuse.

Zolpidem is also sold in South Africa as a generic, such as Austell’s Zolpidem, registered under the same Schedule 5 status as Stilnox.

How is Stilnox dosed, and why is the dose different for women and older adults?

The standard adult dose is 10 mg immediately before bed, and the total must not exceed 10 mg. SAHPRA sets that adult ceiling in Stilnox’s package insert, while a lower 5 mg dose is recommended for women, and the same 5 mg applies to older or debilitated adults, according to SAHPRA.

Women tend to clear zolpidem more slowly than men. In 2013 the US Food and Drug Administration cut the recommended dose for women to 5 mg for exactly that reason, after blood tests showed more of the drug still circulating the next morning. Austell’s insert links the lower dose directly to a lower risk of next-morning impaired driving, alongside a resting period of at least 8 hours before driving, using machinery or working at heights.

Can you drink alcohol on Stilnox, and what is complex sleep behaviour?

No. SAHPRA’s insert says concomitant alcohol is not recommended, because it can enhance the sedative effect and affect the ability to drive the next day. Mixing the two can also raise the risk of complex sleep behaviour: sleepwalking, sleep driving, eating or phone calls carried out with no memory of any of it afterwards.

SAHPRA’s own insert describes that behaviour in plain clinical language: sleepwalking and other associated behaviours such as sleep driving, preparing and eating food, making phone calls or having sex, with amnesia for the event, have been reported in patients who had taken Stilnox and were not fully awake. Alcohol and doses above the maximum both raise that risk, and SAHPRA advises that Stilnox should be stopped if a patient reports this kind of episode.

“Some of the riskiest hours on Stilnox happen with no memory of them at all.”

The concern is serious enough that the FDA added a boxed warning, its strongest safety label, to zolpidem and two related sleep drugs in 2019, after reviewing 66 case reports of sleep driving, sleepwalking and similar activity carried out while not fully awake, some ending in serious injury or death, over 26 years of monitoring. Patients who have already had an episode like this are now advised against taking the drug again.

European regulators went further on the morning after. The EMA’s Committee for Medicinal Products for Human Use recommends against driving or any activity that needs mental alertness for at least 8 hours after taking zolpidem, on top of taking the lowest effective dose, in a single intake, just before bed. SAHPRA’s own insert carries a near-identical figure: the risk of impaired driving rises if Stilnox is taken less than 7 to 8 hours before an activity that needs concentration. The NHS puts the alcohol risk in plain terms too: together, the two can produce sleep so deep that breathing slows and waking becomes difficult.

Why doesn’t Stilnox give you the same sleep as a good night’s rest?

Because Stilnox does not create sleep. It switches off the brain circuits that are keeping a person awake, working on the GABA-A receptor, the main brake on activity in the central nervous system, which is a different mechanism from the one that produces ordinary, restorative sleep.

For most people who end up on Stilnox, the insomnia was rarely just about the mattress. It usually sat on top of something else: a separation being turned over at three in the morning, an evening drinking habit that had quietly grown from one glass to four, a job that would not switch off, grief with nowhere to go in daylight hours. The tablet did not touch any of that. It just turned the volume down for long enough to sleep, which is exactly the job it was designed for, and exactly why it can feel like the only thing that works.

“It was quieting something else long before anyone called it a sleep problem.”

GABA-A receptors are ligand-gated ion channels that carry most of the inhibitory signalling in the central nervous system, and Stilnox works by strengthening that inhibition, mainly at receptors carrying the alpha1 subunit. That quiets the parts of the brain producing racing thoughts, but it is not the same biological process as the sleep architecture the brain builds on its own, which is one reason people often wake up groggy rather than rested.

Part of that grogginess is simple pharmacology. Zolpidem’s half-life runs about 32% longer in older people than in a younger adult, and the NHS notes the drug does not usually stay in the system for more than about 12 hours, which is still long enough to blunt alertness for part of the next morning in anyone sensitive to it.

None of this is unique to a sleeping tablet. Alcohol, benzodiazepines and opioids all quiet an overactive nervous system by more or less the same route, just through different receptors and different substances. The tablet, the drink and the pill are doing the same job from the body’s point of view, even when the person reaching for one of them would never put it in the same sentence as the others.

That is also why insomnia rarely travels alone. It tends to sit on anxiety, on evening drinking that has quietly become part of the routine, or on burnout that never gets properly named, and treating the sleeplessness without treating what sits underneath it is a large part of why the problem comes back. It is the same argument behind our page on dual diagnosis treatment.

What happens when you stop: tolerance, rebound insomnia and dependence?

Stopping Stilnox can bring the original insomnia back, often worse than before, along with tolerance and, in some people, physical or psychological dependence. SAHPRA’s insert describes a transient syndrome in which the symptoms that led to treatment recur in an enhanced form on withdrawal, and the risk climbs with higher doses and longer use.

Tolerance to the sleep-inducing effect can develop after just a few weeks of regular use, according to SAHPRA, which is part of why a tablet that worked well in week one can feel less reliable by week four, tempting a higher dose than was ever prescribed. The NHS describes the same rebound pattern in plain terms: insomnia can come back and be worse than before, often with anxiety and mood changes alongside it. That is a withdrawal effect, not proof the original problem was never treated, and it is a reason stopping suddenly, alone, is not a good idea.

Physical and psychological dependence can develop with Stilnox, and the risk rises with the dose and the length of treatment, and is higher again in people with a history of psychiatric illness or of alcohol or drug misuse, according to the same insert. Where physical dependence has set in, stopping abruptly can bring headache, muscle pain, extreme anxiety, tension and confusion, and in severe cases derealisation, heightened sensitivity to light and noise, hallucinations or seizures, according to Austell’s product information.

None of that is a character flaw. A nervous system that has come to rely on a substance to quiet down does not agree to stop just because a person decides to, and willpower is not really the mechanism in play. That is exactly why coming off something that works on the brain this directly is harder than it looks from the outside, whatever the substance involved.

A seizure, hallucinations or serious confusion during withdrawal, or slowed or difficult breathing after mixing Stilnox with alcohol, needs urgent medical care: call an ambulance on 10177, or 112 from a mobile; in Cape Town the city line is 107 from a landline or 021 480 7700 from a mobile. For support with substance use, the Department of Social Development substance abuse helpline is open on 0800 12 13 14, or SMS 32312.

When does a short course turn into a problem, and how is coming off Stilnox actually managed?

A short course becomes a problem once it runs past the point it was meant to stop, usually around four weeks, or once someone needs more than the prescribed dose to get the same effect. The UK’s approved product information sets the usual length of treatment at 2 days to 4 weeks, and coming off after that point is a decision for the prescribing doctor, not a schedule to follow alone.

Shortest usual course2 days

Maximum, taper included4 weeks

Clinical guidance on stopping sedative-hypnotics describes gradual dose reduction over weeks rather than abrupt stopping, precisely because of the rebound and withdrawal risks described above. That is a clinical process a doctor manages and adjusts, not a fixed timetable a patient can safely run through alone, and it looks different for someone who has taken Stilnox for ten days than for someone who has taken it nightly for a year.

Where withdrawal needs medical supervision, that is what a structured detox is for. At Renewed Life Center, medical detox runs with 24-hour nursing supervision where it is clinically indicated, and any medication is prescribed by a doctor. The starting point is always the same: work out what is actually going on. Sleep, alcohol, anxiety and everything around them are assessed as one picture, because the tablet is rarely the whole story.

For people who need longer support once a taper is finished, structured aftercare is often what keeps a hard-won change from unravelling in the first few months back home.

Book a free, confidential call: 20 to 40 minutes by WhatsApp, video or phone, with no obligation. We reply the same day.

What else do people ask about Stilnox?

This article is general information, not medical advice.

Sources

1. SAHPRA: Stilnox approved package insert (Sanofi-Aventis)
2. Austell: Zolpidem Austell approved package insert
3. PMC: study of how zolpidem acts on GABA-A receptors
4. University of Utah Pharmacy Services: FDA boxed warning alert on zolpidem and related drugs
5. EMA/CMDh: advice on next-morning driving risk with zolpidem
6. NHS: common questions about zolpidem
7. City of Cape Town: emergency contact numbers
8. UK Electronic Medicines Compendium: zolpidem patient information leaflet